ABVX as reported
ABIVAX Société Anonyme reported €8.4M of revenue over the trailing twelve months. 8 reported series are charted on this page, each one as filed.
€8.4M
Revenue, trailing twelve months · to Q3 2025 · every figure below is as filed, with no scoring applied
- Net Income
- −€336M
Net Income · trailing twelve months to Q4 2025
- Free Cash Flow
- −€161M
Free Cash Flow · trailing twelve months to Q4 2025
- Op Margin
- −3487%
Op Margin · trailing twelve months to Q3 2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | €8.4M | n/a | Q3 2025 |
| Net Income | −€336M | n/a | Q4 2025 |
| EPS | −€4.71 | n/a | Q4 2025 |
| Op Margin | −3487% | n/a | Q3 2025 |
| Net Margin | −4530% | n/a | Q3 2025 |
| ROE | 773% | n/a | Q4 2025 |
| ROA | −94% | n/a | Q4 2025 |
| Free Cash Flow | −€161M | n/a | Q4 2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
ABIVAX Société Anonyme (ABVX) - Revenue & ProfitRevenue & ProfitABIVAX Société Anonyme (ABVX)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com